[DOI] [PMC free article] [PubMed] [Google Scholar] 111.Benetti E., Mastrocola R., Vitarelli G., Cutrin J.C., Nigro D., Chiazza F., Mayoux E., Collino M., Fantozzi R
16 However, the burden of gastrointestinal side effects and challenges with long-term adherence limited its broader applicability and underscored the need for more effective and better-tolerated therapeutic alternatives
Common options include GLP-1 injections, GLP-1 injection therapies, and semaglutide injections, all of which deliver the active ingredient through a simple injection schedule
Consistency over time matters more than a single missed day
REGION North America to be the fastest-growing region in the global GLP-1 agonists market during the forecast period The Asia Pacific GLP-1 agonists market is expected to register the highest CAGR during the forecast period